TC
GILD icon

Telemus Capital’s Gilead Sciences GILD Stock Holding History

Telemus Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$1.59M Buy
19,589
+1,788
+10% +$139K 0.13% 123
2023
Q3 		$1.33M Buy
17,801
+14,088
+379% +$1.08M 0.12% 133
2023
Q2 		$286K Buy
3,713
+1,165
+46% +$92.9K 0.02% 268
2023
Q1 		$211K Buy
+2,548
New +$211K 0.02% 304
2019
Q3 		– Sell
-11,160
Closed -$707K – 396
2019
Q2 		$707K Buy
11,160
+770
+7% +$50.7K 0.06% 199
2019
Q1 		$675K Sell
10,390
-2,082
-17% -$138K 0.05% 236
2018
Q4 		$780K Buy
12,472
+2,838
+29% +$198K 0.06% 208
2018
Q3 		$744K Sell
9,634
-268
-3% -$20.2K 0.06% 240
2018
Q2 		$701K Buy
9,902
+271
+3% +$19.1K 0.05% 249
2018
Q1 		$726K Buy
9,631
+1,410
+17% +$112K 0.06% 236
2017
Q4 		$589K Buy
+8,221
New +$624K 0.05% 263
2017
Q1 		– Sell
-43,356
Closed -$3.1M – 338
2016
Q4 		$3.1M Sell
43,356
-18,058
-29% -$1.34M 0.42% 58
2016
Q3 		$4.86M Buy
61,414
+2,211
+4% +$180K 0.54% 29
2016
Q2 		$4.94M Sell
59,203
-731
-1% -$64.9K 0.61% 28
2016
Q1 		$5.51M Buy
59,934
+37,895
+172% +$3.42M 0.91% 20
2015
Q4 		$2.23M Buy
22,039
+2,868
+15% +$298K 0.6% 47
2015
Q3 		$1.88M Buy
19,171
+3,626
+23% +$403K 0.49% 45
2015
Q2 		$1.82M Sell
15,545
-7,650
-33% -$836K 0.46% 45
2015
Q1 		$2.28M Buy
23,195
+355
+2% +$36K 0.55% 38
2014
Q4 		$2.15M Buy
22,840
+334
+1% +$34.5K 0.52% 51
2014
Q3 		$2.4M Sell
22,506
-512
-2% -$50.1K 0.65% 37
2014
Q2 		$1.91M Buy
23,018
+2,994
+15% +$233K 0.5% 49
2014
Q1 		$1.42M Buy
+20,024
New +$1.57M 0.39% 57

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Telemus Capital's GILD Position: Q4 2023 in Review

Telemus Capital increased its Gilead Sciences (GILD) stake by 10% in Q4 2023, buying an estimated $139K and bringing the position to 19,589 shares worth $1.59M. The position accounts for 0.13% of the portfolio, ranked #123.

Telemus Capital first reported a position in GILD in Q1 2014 and has held it in 23 quarters since. The position peaked at $5.51M in Q1 2016. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • Telemus Capital held 19,589 shares of Gilead Sciences worth $1.59M as of Q4 2023.
  • Telemus Capital bought 1,788 Gilead Sciences shares in Q4 2023, an estimated $139K.
  • Gilead Sciences made up 0.13% of Telemus Capital's portfolio in Q4 2023, its #123 holding.
  • Telemus Capital first reported a position in Gilead Sciences in Q1 2014 and has held it in 23 quarters since.
  • Telemus Capital's Gilead Sciences position peaked at $5.51M in Q1 2016.
  • 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Telemus Capital's 13F filing for Q4 2023, filed 1 Feb 2024.